Michael Thomas Henderson, Chief Executive Officer at Apogee Therapeutics, Inc. (APGE), sold 95,046 shares at $133.63 ($2.7M) on 2026-07-08, disclosed to the SEC on 2026-07-10.
Scheduled sale ($2.7M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $133.63 | 20,000 | $2.7M | 100.0% |
| 2 | $0.00 | 75,046 | $0 | 0.0% |
| Total | $28.12 avg | 95,046 | $2.7M | 100% |
| Filing → |
| APGE | SELL | 2026-06-12 | $1.7M | — | Filing → |
| APGE | SELL | 2026-05-15 | $1.6M | — | Filing → |
| SYRE | SELL | 2026-05-08 | $6.0M | — | Filing → |